Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -33.33% vs -99.14% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 2.60% vs -451.74% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -34.24% vs -440.74% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -100.00% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Vicore Pharma Holding AB With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 50.00% vs -50.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -33.33% vs -99.14% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 20.79% vs -20.79% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 2.60% vs -451.74% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 8.31% vs -16.02% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -34.24% vs -440.74% in Mar 2025
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






